MO

Here's What You May Have Missed About Altria(MO)

More and more people are talking about Altria over the last few weeks. Is it worth buying the Tobacco stock at a price of $41.88? Only time will tell. The information below will give you a basic idea of what this investment may entail:

  • Altria has moved -8.0% over the last year, and the S&P 500 logged a change of 13.0%

  • MO has an average analyst rating of hold and is -9.95% away from its mean target price of $46.51 per share

  • Its trailing earnings per share (EPS) is $4.9

  • Altria has a trailing 12 month Price to Earnings (P/E) ratio of 8.5 while the S&P 500 average is 15.97

  • Its forward earnings per share (EPS) is $5.11 and its forward P/E ratio is 8.2

  • Altria is part of the Consumer Defensive sector, which has an average P/E ratio of 24.36 and an average P/B of 4.29

  • MO has reported YOY quarterly earnings growth of 892.2% and gross profit margins of 0.7%

  • The company has a free cash flow of $12.06 Billion, which refers to the total sum of all its inflows and outflows of cash over the last quarter

  • Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; moist smokeless tobacco products and snus products under the Copenhagen, Skoal, Red Seal, and Husky brands; and on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. The company was founded in 1822 and is headquartered in Richmond, Virginia.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS